METHODS	Interventions included a 6-week withdrawal from previous hormone therapy ( baseline ) , followed in randomized order by 12 weeks of oral conjugated equine estrogens ( CEE ) ( 0.625 mg/d ) and 12 weeks of transdermal estradiol ( TD E2 ) ( 0.05 mg/d ) , with oral micronized progesterone ( 100 mg/d ) given continuously during both transdermal estrogen therapy regimens .\